Radiation Oncology Journal10.3857/roj.2014.32.1.23201432123A predictive model to guide management of the overlap region between target volume and organs at risk in prostate cancer volumetric modulated arc therapyMalcolm D. Mattes, Jennifer C. Lee, Sara Elnaiem, Adel Guirguis, N. C. Ikoro, Hani Ashamalla,,
Journal of Radiotherapy in Practice10.1017/s14603969160001942016153263-268Dosimetric comparison between the prostate intensity-modulated radiotherapy (IMRT) and volumetric-modulated arc therapy (VMAT) plans using the planning target volume (PTV) dose–volume factorJames C. L. Chow, Runqing Jiang, Alexander Kiciak, Daniel Markel
Radiology and Oncology10.2478/raon-2018-00422018524461-467Image guided high-dose-rate brachytherapy versus volumetric modulated arc therapy for head and neck cancer: A comparative analysis of dosimetry for target volume and organs at riskHironori Akiyama, Csilla Pesznyák, Dalma Béla, Örs Ferenczi, Tibor Major, Csaba Polgár, Zoltán Takácsi-Nagy,
Radiation Oncology10.1186/s13014-019-1363-42019141Left breast irradiation with tangential intensity modulated radiotherapy (t-IMRT) versus tangential volumetric modulated arc therapy (t-VMAT): trade-offs between secondary cancer induction risk and optimal target coverageDaniel Karpf, Mazen Sakka, Martin Metzger, Gerhard G. Grabenbauer,,
Cancer Management and Research10.2147/cmar.s2731972020Volume 129643-9653

Sparing Organs at Risk with Simultaneous Integrated Boost Volumetric Modulated Arc Therapy for Locally Advanced Non-Small Cell Lung Cancer: An Automatic Treatment Planning Study

Daquan Wang, Jiayun Chen, Xiaodong Zhang, Tao Zhang, Luhua Wang, Qinfu Feng, Zongmei Zhou, Jianrong Dai, Nan Bi,
Journal of Applied Clinical Medical Physics10.1120/jacmp.v14i3.405320131433-12Prostate volumetric-modulated arc therapy: dosimetry and radiobiological model variation between the single-arc and double-arc techniqueJames C.L. Chow, Runqing Jiang,,
Cancer Management and Research10.2147/cmar.s2449012020Volume 122513-2521

Comparison of Radiation-Induced Secondary Malignancy Risk Between Sequential and Simultaneous Integrated Boost for the Treatment of Nasopharyngeal Carcinoma: Intensity-Modulated Radiotherapy versus Volumetric-Modulated Arc Therapy

Emel Haciislamoglu, Yunus Cinar, Mehmet Eren, Emine Canyilmaz, Fatih Gurcan, Lasif Serdar, Adnan Yoney,
Clinical Oncology10.1016/j.clon.2016.11.0172017293e87Survival Data for Patients with High Risk Prostate Cancer Treated with Intensity Modulated Radiotherapy/Volumetric Modulated Arc Therapy at Aberdeen Royal InfirmaryA. Duncan, G. Macdonald, J. Grant,
International Journal of Radiation Oncology*Biology*Physics10.1016/j.ijrobp.2017.06.11332017992E221-E222Comparison of Dose-Volume Histogram Between Intensity-Modulated Proton Therapy Versus Volumetric-Modulated Arc Therapy for the Irradiation of Pelvic Lymph Nodes and Prostate in High-Risk Prostate CancerC.R. Choo, D. Routman, H.L. Schultz, W.S. Harmsen, K.S. Corbin, K.W. Merrell, W.W. Wong, B.J. Stish, B.J. Davis, T.M. Pisansky, T.J. Whitaker,
Physica Medica10.1016/j.ejmp.2016.07.128201632295Dosimetric comparison of Volumetric Modulated Arc Therapy and intensity-modulated radiotherapy for bilateral hip prostheses prostate cancer patientMorera Daniel, Marí Adrià,